{"title":"Bismuth‐based quadruple therapy vs concomitant therapy for Helicobacter pylori eradication—a real‐world experience","authors":"D. M. Thomas, K. Devadas","doi":"10.1002/ygh2.486","DOIUrl":null,"url":null,"abstract":"Both bismuth‐based quadruple therapy (BQT) and concomitant therapy (CCT) are first‐line regimens for Helicobacter pylori eradication. We compared the efficacy and adverse effects of both regimens in day‐to‐day clinical practice.","PeriodicalId":12480,"journal":{"name":"GastroHep","volume":"226 1","pages":"388 - 393"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GastroHep","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ygh2.486","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Both bismuth‐based quadruple therapy (BQT) and concomitant therapy (CCT) are first‐line regimens for Helicobacter pylori eradication. We compared the efficacy and adverse effects of both regimens in day‐to‐day clinical practice.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
